STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Reported by STAT News · all stories from statnews.com
Editorial digest
Various lobbying groups and trade organizations are actively engaged in efforts to help define how individual states will oversee medical AI technologies. Their advocacy seeks to shape the emerging regulatory environment.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/3/2026
STAT+: FDA, CMS look to collaborate with states on health AI
Federal regulators at the FDA and CMS plan to partner with state authorities regarding medical artificial intelligence.
- Trusted health newsroom11/6/2026
STAT+: After Medicare punts RPM overhaul to 2029, advocates see window to fight back
Advocates plan to challenge Medicare's remote monitoring overhaul after officials postponed the policy update to 2029.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.
- Trusted health newsroom11/5/2026
STAT+: What the midterms could mean for the future of health AI
Upcoming midterm election outcomes could reshape regulatory policies and federal oversight for medical artificial intelligence technologies.
- Trusted health newsroom10/29/2026
STAT+: The EPIC investigation, and a Teladoc surprise
New reporting examines an inquiry into Epic alongside an unexpected update involving telehealth company Teladoc.
- Trusted health newsroom11/5/2026
STAT+: Medicare delays controversial remote patient monitoring rule to 2029
Federal regulators have postponed a contentious Medicare remote patient monitoring policy update until 2029.
